Banner Slide

Going further to bring better todays to even more people with cancer

Building better todays for more patients worldwide

At Helsinn, we’ve made it our mission to improve the everyday lives of patients. We’ve been a family-run pharmaceutical company since we were founded over 40 years ago, guided by our values of integrity, respect and with a 360-degree approach to quality that runs through everything we do. Today, we’re leading the way in supportive care in cancer, and are committed to building better todays for more patients worldwide.

Our Business

The Helsinn Group is one of the world's leading supportive cancer care companies, with a comprehensive portfolio of medicines and therapies helping to improve the lives of patients in countries around the world.

Learn more

Corporate Social Responsibility and Sustainability

Sustainability is becoming an increasingly central part of Helsinn’s culture and business strategy. Integrity, quality and respect have always been at the core of our business, but increasingly, organisations are aware that they function as part of an ecosystem to which they have a responsibility. Care for the communities in which we operate, and stewardship of our environment, are as important to our long-term future as the economic bottom line.

Learn more

Our Products

The strength of the Helsinn model is reflected in the product candidates that we have transformed into sustainable market successes.

Learn more

Our Building Blocks

News & Events

Helsinn Advanced Synthesis wins across all categories 2017 CMO Leadership Awards

Consistent strong performance sees Helsinn Advanced Synthesis SA win six awards for the third consecutive year in Qualit...

Read more

March 23 HAS wins across all categories at 2017 CMO Leadership Awards Waldo Mossi and Allison Vavala receive awards

Helsinn Advanced Synthesis announces investment - Helsinn Advanced Synthesis ann...

Significant new investment totaling CHF15m,supported by Canton of Ticino, prompted by expanding demand for anticancer th...

Read more

Helsinn Provides Grant for ESMO’s Preceptorship Course on Supportive and Palliat...

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, announces that the Group has provided a g...

Read more

microphone 704255 1920 small2

Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreem...

Anti-emetic products covered under expanded agreements include ALOXI® and AKYNZEO®. Both are prophylactic agents for the...

Read more

globe 32299 1280

Helsinn Group Launches “Helsinn Cares” Patient Support Services

Patient Assistance Program and Voucher Program will support both insured and uninsured patients in the United States get...

Read more

HelsinnCares Stacked TM RGB 40